These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20145640)

  • 1. Defining the antigen determinant for T-cell-mediated contact dermatitis using p-phenylenediamine: a gateway to chemical immunology.
    Elliott G; Das PK
    J Invest Dermatol; 2010 Mar; 130(3):641-3. PubMed ID: 20145640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of p-phenylenediamine-albumin binding sites and T-cell responses to hapten-modified protein.
    Jenkinson C; Jenkins RE; Aleksic M; Pirmohamed M; Naisbitt DJ; Park BK
    J Invest Dermatol; 2010 Mar; 130(3):732-42. PubMed ID: 19710686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mechanistic investigation into the irreversible protein binding and antigenicity of p-phenylenediamine.
    Jenkinson C; Jenkins RE; Maggs JL; Kitteringham NR; Aleksic M; Park BK; Naisbitt DJ
    Chem Res Toxicol; 2009 Jun; 22(6):1172-80. PubMed ID: 19469519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A laboratory test based on determination of cytokine profiles: a promising assay to identify exposition to contact allergens and predict the clinical outcome in occupational allergic contact dermatitis.
    Bordignon V; Palamara F; Altomonte G; Sperduti I; Pietravalle M; Cavallotti C; Cordiali-Fei P; Fuggetta MP; Cristaudo A; Ensoli F
    BMC Immunol; 2015 Feb; 16():4. PubMed ID: 25651756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Para-phenylenediamine-specific lymphocyte activation test: a sensitive in vitro assay to detect para-phenylenediamine sensitization in patients with severe allergic reactions.
    Kneilling M; Caroli U; Grimmel C; Fischer J; Eichner M; Wieder T; Maier FC; Röcken M; Biedermann T
    Exp Dermatol; 2010 May; 19(5):435-41. PubMed ID: 20113350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergic and irritant contact dermatitis.
    Nosbaum A; Vocanson M; Rozieres A; Hennino A; Nicolas JF
    Eur J Dermatol; 2009; 19(4):325-32. PubMed ID: 19447733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro primary sensitization of hapten-specific T cells by cultured human epidermal Langerhans cells--a screening predictive assay for contact sensitizers.
    Krasteva M; Peguet-Navarro J; Moulon C; Courtellemont P; Redziniak G; Schmitt D
    Clin Exp Allergy; 1996 May; 26(5):563-70. PubMed ID: 8735869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of allergenic and immunogenic functions in contact sensitivity to para-phenylenediamine.
    Krasteva M; Nicolas JF; Chabeau G; Garrigue JL; Bour H; Thivolet J; Schmitt D
    Int Arch Allergy Immunol; 1993; 102(2):200-4. PubMed ID: 8400900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elicitation response characteristics to mono- and to N,N'-diacetyl-para-phenylenediamine.
    Blömeke B; Pietzsch T; Merk HF
    Contact Dermatitis; 2008 Jun; 58(6):355-8. PubMed ID: 18503685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Afferent and efferent phases of allergic contact dermatitis (ACD) can be induced after a single skin contact with haptens: evidence using a mouse model of primary ACD.
    Saint-Mezard P; Krasteva M; Chavagnac C; Bosset S; Akiba H; Kehren J; Kanitakis J; Kaiserlian D; Nicolas JF; Berard F
    J Invest Dermatol; 2003 Apr; 120(4):641-7. PubMed ID: 12648229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of T-cells from allergic patients and volunteers by p-phenylenediamine and Bandrowski's base.
    Coulter EM; Jenkinson C; Wu Y; Farrell J; Foster B; Smith A; McGuire C; Pease C; Basketter D; King C; Friedmann PS; Pirmohamed M; Park BK; Naisbitt DJ
    J Invest Dermatol; 2008 Apr; 128(4):897-905. PubMed ID: 17914451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple positive allergic reactions from patch testing to p-phenylenediamine and azo dyes. Is this a frequent risk and can it be reduced?
    Winhoven SM; Rutter KJ; Beck MH
    Contact Dermatitis; 2008 Mar; 58(3):182-3. PubMed ID: 18279168
    [No Abstract]   [Full Text] [Related]  

  • 13. Dissection of antigenic and irritative effects of epicutaneously applied haptens in mice. Evidence that not the antigenic component but nonspecific proinflammatory effects of haptens determine the concentration-dependent elicitation of allergic contact dermatitis.
    Grabbe S; Steinert M; Mahnke K; Schwartz A; Luger TA; Schwarz T
    J Clin Invest; 1996 Sep; 98(5):1158-64. PubMed ID: 8787679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin contact irritation conditions the development and severity of allergic contact dermatitis.
    Bonneville M; Chavagnac C; Vocanson M; Rozieres A; Benetiere J; Pernet I; Denis A; Nicolas JF; Hennino A
    J Invest Dermatol; 2007 Jun; 127(6):1430-5. PubMed ID: 17273160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-immune response relationships of hapten-modified collagen II peptides in a T-cell model of allergic contact dermatitis.
    Holmdahl M; Ahlfors SR; Holmdahl R; Hansson C
    Chem Res Toxicol; 2008 Aug; 21(8):1514-23. PubMed ID: 18616296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro sensitization of human T cells with hapten-treated Langerhans cells: a screening test for the identification of contact allergens.
    Krasteva M; Moulon C; Péguet-Navarro J; Courtellemont P; Redziniak G; Schmitt D
    Curr Probl Dermatol; 1996; 25():28-36. PubMed ID: 8787586
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pathomechanisms of the elicitation phase of allergic contact dermatitis].
    Riemann H; Schwarz T; Grabbe S
    J Dtsch Dermatol Ges; 2003 Aug; 1(8):613-9. PubMed ID: 16296151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hapten-induced contact hypersensitivity, autoimmune reactions, and tumor regression: plausibility of mediating antitumor immunity.
    Erkes DA; Selvan SR
    J Immunol Res; 2014; 2014():175265. PubMed ID: 24949488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of interleukin-9 in patients with allergic contact dermatitis caused by p-phenylenediamine.
    Baeck M; Herman A; de Montjoye L; Hendrickx E; Chéou P; Cochez PM; Dumoutier L
    Contact Dermatitis; 2018 Dec; 79(6):346-355. PubMed ID: 30264909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell immune responses to haptens. Structural models for allergic and autoimmune reactions.
    Weltzien HU; Moulon C; Martin S; Padovan E; Hartmann U; Kohler J
    Toxicology; 1996 Feb; 107(2):141-51. PubMed ID: 8599173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.